Sequential [177Lu]Lu-PSMA-617 and docetaxel versus docetaxel in patients with metastatic hormone-sensitive prostate cancer (UpFrontPSMA): a multicentre, open-label, randomised, phase 2 study

Arun Azad, Mathias Bressel, Hsiang Tan, Mark Voskoboynik, Aneta Suder, Andrew Weickhardt, Alexander Guminski, Roslyn J. Francis, Javad Saghebi, Nattakorn Dhiantravan, Anthony M. Joshua, Louise Emmett, Lisa G. Horvath, Declan G. Murphy, Edward Hsiao, Bavanthi Balakrishnar, Peter Lin, Andrew Redfern, W A Macdonald, Siobhan Ng, Sze-Ting Lee, David A. Pattison, David Nadebaum, Ian Kirkwood, Michael S. Hofman, T Akhurst, R Alipour, L Au, P Banks, B Emerson, N Hussain, M Haskali, J Lewin, R Linklater, L Kostos, R Kashyap, P Krishanth, G Kong, A Kumar, D Murphy, P Roselt, S Sandhu, M Scalzo, B Tran, R Wallace, L Spain, H Bourke, A Milton, D Russo, M Bills, C Chew, W Hsieh, B Crouch, D Smyth, S Pandelus, H Lam, C Gan, J Goh, A Scott, U Hafeez, U Ackermann, K Young, A Poon, K Pathmaraj, G Schembri, P Roach, D Bailey, T Hung, A Asad, T Hagan, J Watts, E Campbell, W Chua, A Pal, M Crumbaker, A Nguyen, A Yam, J Chen, L Ardolino, K Kongrak, L Ratnayake